Data On CombinatoRx, Incorporated Drug Candidates CRx-102 And CRx-139 To Be Presented At Upcoming ACR Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--CombinatoRx, Incorporated (NASDAQ: CRXX) today announced that posters regarding its product candidates, CRx-102 and CRx-139 will be presented at the American College of Rheumatology (ACR) meeting November 10-15, 2006 in Washington, DC.

MORE ON THIS TOPIC